Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-28
1990-07-31
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549264, 549214, 536 71, 514 30, 514 63, A61K 31364, C07D31300
Patent
active
049451057
ABSTRACT:
Derivatives of milbemycins D, A.sub.3 and A.sub.4 and of the corresponding sec-butyl compound have a halogen atom at the 13-position; at the 5-position, they have an oxygen (keto) atom, an oxime group or a substituted oxime group. They may be prepared from known compounds by any appropriate combination of halogenation, ketonization and oximation.
REFERENCES:
patent: Re32034 (1985-11-01), Chabala et al.
patent: 3950360 (1976-04-01), Aoki et al.
patent: 4134973 (1979-01-01), Fisher et al.
patent: 4156720 (1979-05-01), Fisher et al.
patent: 4173571 (1979-11-01), Chabala et al.
patent: 4346171 (1982-08-01), Takiguchi et al.
patent: 4423209 (1983-12-01), Mrozik
patent: 4547520 (1985-10-01), Ide et al.
H. Mrozik et al, Tetrahedron Letters, vol. 24(48) (1983), pp. 53333-53336.
Frei Bruno
Kitano Noritoshi
Nishida Akira
O'Sullivan Anthony
Sato Kazuo
Raymond Richard L.
Russell Mark W.
Sankyo Company Limited
LandOfFree
13-Halomilbemycin derivatives, their preparation and composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 13-Halomilbemycin derivatives, their preparation and composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 13-Halomilbemycin derivatives, their preparation and composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1399035